Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 229   

Articles published

SNY 47.00 +0.95 (2.06%)
price chart
Cerdelga by Genzyme Corporation of Sanofi SA (ADR) (NYSE:SNY)
Genzyme Corporation, which is a biotechnology company based in Massachusetts and a subsidiary of Sanofi SA (ADR) (NYSE:SNY), made it public that it has developed a drug as a cure for type 1 of Gaucher disease (GD1).
Sanofi SA (ADR) Witness Large Inflow of Money
Sanofi SA (ADR) (NYSE:SNY) dropped -0.98% or -0.46 points to trade at $46.42 per share. As per the latest trading data available, the net money flow stood at $2.02 million as the counter received $2.98 million in upticks and gave away $0.96 million in ...
First Call Rating Update on Sanofi SA (ADR)
Sanofi SA (ADR) (NYSE:SNY) has received a Buy rating from First Call in their declaration. The rating agency has disclosed the information in the equity research recommendation.
Sanofi SA (ADR) Analyst Rating Update
Sanofi SA (ADR) (NYSE:SNY) has received a Underperform rating, according to the latest rank of 5 from research firm, Zacks.
Sanofi SA (ADR) (SNY) Trading at Discount to Fair Value
�What it really all came down to, last quarter they reported disappointing guidance for their diabetes franchise, and probably even more importantly what affected the stock was that the CEO was fired due to conflicts with the board of directors of the ...
Has Sanofi SA (ADR) (NYSE:SNY) Fallen Enough?
Sanofi's diabetes franchise appears to be in trouble, with its drug Lantus facing increased competition. The company has projected flat sales for its diabetes offerings, in great part due to increased generic competition when Lantus loses its patent ...
Sanofi SA (ADR) (SNY) And Netflix, Inc. (NFLX) Executives Entangled In ...
When Sanofi SA (ADR) (NYSE:SNY) CEO Christopher Viehbacher was sacked recently, it was believed that the disagreement between him and the board was the reason of his unfortunate exit.
Whistleblower Lawsuit Accuses Sanofi SA (SNY), Ousted CEO Of Kickback ...
Sanofi SA (ADR) (NYSE:SNY) has found itself caught in a whistleblower lawsuit, where a former employee is accusing the company of funneling $34 million in kickbacks and incentive payments to various doctors and pharmacies, influencing them to prescribe ...
Related articles »  
Sanofi Fires CEO Following Clash With Board
Sanofi SA (ADR) (SNY) announced today that the company's board has decided to oust Chief Executive Officer Christopher Viehbacher, finally putting the rumors to rest.
Sanofi Ousts CEO Christopher Viehbacher, Stock Down - Update  Nasdaq
Related articles »  
Sanofi SA (SNY) Continues Search For Head; Smith & Nephew (SNN) CEO Out ...
In an employee meeting, Smith & Nephew plc (ADR) (NYSE:SNN) Chief Executive Olivier Bohuon dismissed rumors of his plans to leave the medical-device maker to join Sanofi SA (ADR) (NYSE:SNY), as per reports from Bloomberg. This implies that Sanofi, ...
Related articles »